NIH-funded research R01 grant

Understanding immune responses after cardiac arrest

Official title: Protective adaptive immune mechanisms after cardiac arrest

Funded at Mainehealth · NIH-11064814 · Data updated 2026-11-12

This study is looking at how the immune system helps the heart and brain heal after a cardiac arrest, especially focusing on certain immune cells that might reduce inflammation and improve recovery, with the goal of finding new treatments for people who have gone through this experience.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMainehealth
NIH-funded
Lab location1 site (Portland, United States)
Project startApril 2, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$579,700
NIH project number5R01HL173118-02
Project IDNIH-11064814 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced a cardiac arrest and are undergoing recovery.

Less likely to help

Patients who have not experienced cardiac arrest or have other unrelated health conditions may not benefit from this research.

What this research studies

This research investigates how the immune system responds after a cardiac arrest, focusing on protective mechanisms that may help reduce inflammation and improve recovery. It aims to explore the role of specific immune cells, particularly CD73-expressing lymphocytes, in controlling inflammation in the heart and brain following cardiac arrest. The study will utilize both human patient data and mouse models to assess the effectiveness of adoptive cell therapy and the formation of immune cell complexes that promote healing. By understanding these processes, the research seeks to identify new therapeutic strategies for patients who have experienced cardiac arrest.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance recovery and improve outcomes for patients who suffer from cardiac arrest.

How similar studies have gone: Other research has shown promising results in using immune modulation to improve outcomes after cardiac events, suggesting that this approach may be effective.

Where this research is happening

  • Mainehealth
    Portland, United States
    Active

Researchers

  • Principal investigator: Ryzhov, Sergey — Mainehealth
  • Study coordinator: Ryzhov, Sergey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.